Latest From Biotech Now

TPP and Innovation in the Bioeconomy: The Need for 12 Years of Data Protection

BIO Logo Horizontal 4C copy

A few weeks ago, BIO submitted a letter and white paper (PDF) to the U.S. Trade Representative outlining recommendations for policies to pursue with TPP negotiating partners to ensure intellectual property protection for innovative biologic products. Standards that enable biotechnology companies to protect and leverage their intellectual property are of critical importance to companies seeking breakthrough treatments and cures for patients in need worldwide. Implementing standards of protection that effectively protect innovation for biological products within the TPP region Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , ,

How Do Patients Get Their Medicines During Hurricanes?

hurricane-season-hurricane-earl-2010-1024x576-940x198

Hurricane season has grown to last six months – running June through November. This means we are well into 2013′s hurricane season. Although the Eastern and Southern United States have seen their fair share of bad storms in the last few years, the most recent major hurricane to strike the U.S. was Hurricane Wilma in 2005. Surprisingly Hurricane Sandy in October of 2012 was not technically was not a hurricane, but a confluence of major Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , ,

When is the Evidence “Enough” to Make a Health Care Decision?

Protein_BRCA1_PDB_1jm7

At any given time, work is taking place in hundreds of laboratories throughout the country to develop new and better ways of combating disease and protecting our health and well-being.  As the results of this research becomes more widely known, how long does it take before this new information changes the actual practice of medicine in hospitals, clinics and physicians’ offices? According to the Institute of Medicine, it takes an average of 17 years for Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , ,

These three tax tweaks can help new and small businesses create a half million jobs

shutterstock_26191726

This story from JD Harrison at the Washington Post highlights a new report from Ernst & Young that illustrates the economic impact of three tax proposals intended to help small businesses spur innovative research and development. The report indicates that the three tax revisions, if enacted together, could drive up research and development investments by more than $20 billion and create an estimated 623,000 new jobs at new and small firms. The report outlines the Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , , ,

NORD Urges Congress: Don’t Cut Orphan Drug Tax Credit

patient

This week, the National Organization of Rare Disorders (NORD) and more than 70 patient organizations sent a letter to key members of Congress in support of maintaining the Orphan Drug Tax Credit. Representing millions of American men, women and children suffering from rare diseases, the organizations voice strong support for the Orphan Drug Tax Credit (ODTC) and urge Congress to keep this critical tax credit in place as tax reform proposals are developed. According to Read More >

Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,